YS Biopharma Co., Ltd. (YS)
$
1.02
+0.09 (8.82%)
Key metrics
Financial statements
Free cash flow per share
0
Market cap
305.9 Million
Price to sales ratio
0.7627
Debt to equity
1.1761
Current ratio
0.9363
Income quality
0
Average inventory
201.8 Million
ROE
-0.7106
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
News
prnewswire.com
a year ago
GAITHERSBURG, Md. , May 24, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com
a year ago
GAITHERSBURG, Md. , May 21, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com
a year ago
GAITHERSBURG, Md. , May 7, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com
a year ago
GAITHERSBURG, Md. , April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
seekingalpha.com
a year ago
YS Biopharma Co., Ltd. (NASDAQ:YS ) Q3 2024 Earnings Conference Call April 19, 2024 8:00 AM ET Company Participants Alyssa Li - Director, Investor Relations David Shao - President & Chief Executive Officer Zenaida Mojares - Chief Medical Officer Brenda Wu - Chief Financial Officer Conference Call Participants Hunter Diamond - Diamond Equity Research Operator Ladies and gentlemen, thank you for standing by and welcome to YS Biopharma's Earnings Call for the First Nine Months of Fiscal Year 2024.
prnewswire.com
a year ago
GAITHERSBURG, Md. , April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com
a year ago
GAITHERSBURG, Md. , April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com
a year ago
GAITHERSBURG, Md. , April 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com
a year ago
GAITHERSBURG, Md. , April 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
prnewswire.com
a year ago
GAITHERSBURG, Md. , April 3, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd.
See all news
